Skip to main content
    O

    Organogenesis Holdings Inc (ORGO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.80
    -0.01 (-0.86%)

    Market Cap: $105.15M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Organogenesis Holdings Inc (ORGO) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Organogenesis Holdings are OrganiGram Holdings (OGI), Journey Medical (DERM) and Akebia Ther (AKBA). By market cap, Organogenesis Holdings ranks 10th of the 13 companies on this page; Emergent Biosolutions (EBS) is the largest at $297.69M.

    Peer Comparison

    ORGO's ROIC of -66.3% is below the peer median of -11.7%, and its revenue growth of -69.9% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Organogenesis Holdings (ORGO)$105.15MN/A0.3x-38.5%-66.3%-69.9%0.00%
    OrganiGram Holdings Inc (OGI)$116.93MN/A0.4x28.0%-1.2%49.4%0.00%
    Journey Medical Corp (DERM)$122.24MN/A1.5x-7.3%-2.8%7.6%0.00%
    Akebia Ther (AKBA)$131.67MN/A0.6x-22.6%-38.9%-37.2%0.00%
    Lifecore Biomedical Inc. (LFCR)$243.36MN/AN/A-66.8%N/A-18.6%0.00%
    Cumberland Pharmaceuticals Inc (CPIX)$88.16MN/A3.1x148.6%N/A-74.0%28.79%
    Cardiol Therapeutics Inc Class A (CRDL)$127.69MN/AN/A0.0%N/A0.0%0.00%
    Anika Therapeutics Inc (ANIK)$179.50M18.7x1.4x-1.4%N/A10.0%0.00%
    InterCure Ltd. (INCR)$49.17MN/AN/A-13.2%N/A23.9%0.00%
    Canopy Growth Corp (CGC)$252.32MN/AN/A-88.1%N/A22.0%0.00%
    SIGA Technologies Inc (SIGA)$196.88M475.0xN/A1.3%N/A-49.7%0.00%
    Emergent Biosolutions Inc (EBS)$297.69MN/A0.5x-40.2%-20.5%-52.4%0.00%
    Talphera Inc. (TLPH)$47.07MN/AN/A0.0%N/A0.0%0.00%
    Peer median$129.68M246.9x1.0x-4.4%-11.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Organogenesis Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    OrganiGram Holdings Inc (OGI)
    Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company is headquartered in Moncton, Canada.
    OGI competitors
    Journey Medical Corp (DERM)
    Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
    DERM competitors
    Akebia Ther (AKBA)
    Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of kidney therapies for patients with kidney disease.
    AKBA competitors
    Lifecore Biomedical Inc. (LFCR)
    Lifecore Biomedical, Inc., is an integrated contract development and manufacturing organization in the United States and internationally.
    LFCR competitors
    Cumberland Pharmaceuticals Inc (CPIX)
    Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development...
    CPIX competitors
    Cardiol Therapeutics Inc Class A (CRDL)
    Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment...
    CRDL competitors
    Anika Therapeutics Inc (ANIK)
    Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally.
    ANIK competitors
    InterCure Ltd. (INCR)
    Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries...
    Canopy Growth Corp (CGC)
    Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes...
    CGC competitors
    SIGA Technologies Inc (SIGA)
    SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States.
    SIGA competitors
    Emergent Biosolutions Inc (EBS)
    Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations...
    EBS competitors
    Talphera Inc. (TLPH)
    Talphera Inc. is a pioneering biotechnology company dedicated to advancing peptide-based therapies for rare diseases and significant unmet medical needs.
    TLPH competitors

    Frequently Asked Questions About ORGO

    Who are Organogenesis Holdings' main competitors?

    The companies most similar to Organogenesis Holdings include OrganiGram Holdings (OGI), Journey Medical (DERM), Akebia Ther (AKBA), Lifecore Biomedical (LFCR) and Cumberland Pharmaceuticals (CPIX), listed from the closest match.

    Who is Organogenesis Holdings' biggest competitor?

    Emergent Biosolutions (EBS) is the largest of the similar companies at $297.69M; OrganiGram Holdings (OGI) is the closest match by business profile, size, sector and industry.

    How does ORGO stock compare with its competitors?

    ORGO's P/S is 0.3x against a peer median of 1.0x; its net margin is -38.5% against a peer median of -4.4%.

    Which of Organogenesis Holdings' competitors pays a higher dividend?

    Organogenesis Holdings pays no dividend. Cumberland Pharmaceuticals (CPIX) has a higher forward dividend yield; Cumberland Pharmaceuticals (CPIX) has the highest at 28.79%.

    Is Organogenesis Holdings bigger than its competitors?

    No. Organogenesis Holdings is 10th by market cap among the 13 companies on this page; the largest is Emergent Biosolutions (EBS) at $297.69M.